Company: LHI
Filing Date: 2025-09-29
Form Type: F-1/A
Source: 0001213900-25-092499
Chunk: 64

Company: Living Homeopathy International Ltd.
Filing Date: 2025-09-29
Form: F-1/A
Chunk 64
---
 companies listed overseas, and to establish and improve the system of extraterritorial application
of the PRC securities laws.

On December 28, 2021, the CAC and other PRC authorities promulgated the Cybersecurity Review Measures, which took effect on February 15, 2022. In addition, the Cybersecurity Law, which was adopted by the Standing Committee of the National People’s Congress on November 7, 2016 and came into force on June 1, 2017, and the Cybersecurity Review Measures, or the “Review Measures”, provide that personal information and important data collected and generated by a critical information infrastructure operator, or a “CIIO”, in the course of its operations in mainland China must be stored in mainland China, and if a CIIO purchases internet products and services that affect or may affect national security, it should be subject to national security review by the CAC together with competent departments of the State Council. On November 14, 2021, CAC published the Regulations on the Network Data Security Administration Draft, or the “Data Security Regulations Draft”, to solicit public opinion and comments. Under the Data Security Regulations Draft, an overseas initial public offering to be conducted by a data processor processing the personal information of more than one million individuals shall apply for a cybersecurity review. Data processor means an individual or organization that independently makes decisions on the purpose and manner of processing in data processing activities, and data processing activities refers to activities such as the collection, retention, use, processing, transmission, provision, disclosure, or deletion of data.

Currently we do not expect the Review Measures
to have an impact on the business and operations of Living Homeopathy Hong Kong, or this offering, because (i) Living Homeopathy Hong
Kong is incorporated and operating in Hong Kong without any subsidiary or VIE structure in mainland China, and it is unclear whether
the Review Measures shall be applied to a Hong Kong company; (ii) as of the date of this prospectus, Living Homeopathy Hong Kong has
not collected and stored personal information of any individual customers of mainland China and possesses personal information of
less than one million individuals in the PRC and we have never been recognized as a critical information infrastructure operator in the
PRC; and (iii) as of the date of this prospectus, Living Homeopathy Hong Kong has not been informed by any governmental authority of
mainland China of any requirement that it file for a cybersecurity review for the offering. As of the date